BeOne Medicines
ONC
#530
Rank
HK$357.99 B
Marketcap
HK$3,134
Share price
-0.97%
Change (1 day)
13.77%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Half-year Reports

Thumbnail BeOne Medicines Half-year Report 2026-h1

Half-year Report 2026-h1

Language: English

View Half-year Report
Thumbnail BeOne Medicines Half-year Report 2025-h1

Half-year Report 2025-h1

Language: English

View Half-year Report
Thumbnail BeOne Medicines Half-year Report 2021-h1

Half-year Report 2021-h1

Language: English

View Half-year Report
Thumbnail BeOne Medicines Half-year Report 2020-h1

Half-year Report 2020-h1

Language: English

View Half-year Report
Thumbnail BeOne Medicines Half-year Report 2019-h1

Half-year Report 2019-h1

Language: English

View Half-year Report
Thumbnail BeOne Medicines Half-year Report 2018-h1

Half-year Report 2018-h1

Language: English

View Half-year Report